Manzamine A
Manzamine A, an orally active beta-carboline alkaloid, inhibits specifically GSK-3β and CDK-5 with IC50s of 10.2 μM and 1.5 μM, respectively. Manzamine A targets vacuolar ATPases and inhibits autophagy in pancreatic cancer cells. Manzamine A has antimalarial and anticancer activities. Manzamine A also shows potent activity against HSV-1[1][2][3][4].
Product Specifications
CAS Number
[104196-68-1]
Product Name Alternative
Keramamine A
UNSPSC
12352005
Hazard Statement
H302
Target
Autophagy; CDK; GSK-3; HSV; Parasite; Proton Pump
Type
Natural Products
Related Pathways
Anti-infection; Autophagy; Cell Cycle/DNA Damage; Membrane Transporter/Ion Channel; PI3K/Akt/mTOR; Stem Cell/Wnt
Applications
COVID-19-anti-virus
Field of Research
Cancer; Infection; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/manzamine-a.html
Purity
98.2
Solubility
DMSO : 10 mg/mL (ultrasonic)
Smiles
O[C@]1(CC/C=C\CCCC2)[C@@]3([H])[C@@](C[C@@]4([H])N3CCCC/C=C\4)(C[N@@]2CC5)[C@]5([H])C(C6=C(NC7=CC=CC=C87)C8=CC=N6)=C1
Molecular Formula
C36H44N4O
Molecular Weight
548.76
Precautions
H302
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
CDK5; GSK-3β; HSV-1; Plasmodium
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items